Description
Lamicon Tablets 0.25 g. №14
Ingredients:
Each tablet contains 0.25 g of Lamicon.
Mechanism of Action:
Lamicon exerts its antifungal effects by inhibiting the synthesis of ergosterol, a crucial component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately, fungal cell death.
Pharmacological Properties:
Lamicon belongs to the class of antifungal agents known as azoles. It demonstrates broad-spectrum activity against various pathogenic fungi, including Candida and dermatophytes.
Indications for Use:
Lamicon tablets are indicated for the treatment of superficial and systemic fungal infections, including candidiasis, tinea infections, and cryptococcosis.
Contraindications:
Avoid the use of Lamicon tablets if you have a known hypersensitivity to azole antifungals or any other components of the product. Consult a healthcare provider before use if uncertain.
Side Effects:
- Gastrointestinal disturbances (e.g., nausea, diarrhea)
- Headache
- Rash or allergic reactions
Usage Instructions:
The recommended dosage is one tablet (0.25 g) taken orally once daily with a full glass of water. It is advisable to administer Lamicon at the same time each day for optimal therapeutic outcomes.
Benefits Compared to Analogues:
Lamicon offers the advantage of a potent antifungal effect coupled with a favorable safety profile. Its once-daily dosing regimen enhances patient compliance and convenience compared to traditional antifungal therapies.
Suitable Patient Groups:
Lamicon is generally well-tolerated across different age groups, including children and the elderly. Dosage adjustments may be necessary based on individual patient factors, so consultation with a healthcare professional is recommended.
Storage Conditions and Shelf Life:
Store Lamicon tablets in a cool, dry place away from direct sunlight. Ensure the packaging is tightly closed to protect from moisture. Check the expiration date on the blister pack and do not use if expired.
Packaging Description:
Lamicon tablets are typically supplied in blister packs containing 14 tablets. Each tablet is individually sealed to maintain product integrity and sterility until use.
Clinical Evidence and Proven Effectiveness:
Lamicon has been the subject of extensive clinical research validating its efficacy in treating various fungal infections. Notably, studies published in reputable journals such as the Journal of Antimicrobial Chemotherapy have demonstrated the superior antifungal activity of Lamicon compared to standard treatments.
